"The first GLP-1 drug was approved by the FDA in 2005 , with Ozempic following in 2017 and Mounjaro in 2022 ." National Academy of Medicine How did GLP-1s become so popular so quickly
Accordingly, moderate lean tissue decline observed during GLP-1RA-induced weight loss could be interpreted as a physiological component of body composition change rather than evidence of pathological sarcopenia, unless accompanied by functional deterioration
In contrast, stomach-related side effects like nausea, vomiting, and diarrhea are much more common than any reproductive or menstrual effects
Perhaps it's best read as an illustration of the human body's interconnectedness that we are one system, and it, therefore, stands to reason that one drug can have multiple uses
Steven Davis, board-certified plastic surgeon at Davis Cosmetic Plastic Surgery and founder of Davis Aesthetic Weight Loss, has seen firsthand how these medications can support a comprehensive weight loss strategy tailored to individual needsincluding those of male patients